Genitourinary Cancer News

Sumanta K. Pal, MD, FASCO, expressed a mix of emotions.

Allen S. Ho, MD, did not wait to promote active surveillance when he started practicing medicine a decade ago.

More than 20% of patients with cancer participate in some form of clinical study, and that number is considered a “floor” estimate, according to study results published in Journal of Clinical Oncology.

New guidelines for vaccinating adults with solid or hematologic cancers detailed the importance of vaccination optimization, multidisciplinary coordination and vaccination of household members.

The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki for the treatment of adults with unresectable or metastatic HER2-positive solid tumors who received previous systemic therapy and lack additional treatment options.

Pfizer Inc. and its chairman/CEO, Albert Bourla, PhD, will be awarded the 2024 AACR Outstanding Achievement Award for Service to Cancer Science and Medicine during the American Association for Cancer Research Annual Meeting in San Diego.

Most of the major cancer clinical trial centers in the U.S. are located near more affluent and white populations compared with the national average, according to results published in JAMA Oncology.

Neoadjuvant chemotherapy followed by consolidative lymphadenectomy provided a significant survival benefit among adults with locally advanced penile squamous cell carcinoma who responded to treatment, study results suggest.

Individuals with tooth agenesis may be more likely to develop several different cancer types from childhood through young adulthood, according to results published in JAMA Network Open.

Individuals with elevated and worsening metabolic syndrome had an increased risk for developing an array of cancer types compared with those who did not, according to results published in Cancer.